Radium-223 for bone predominant metastatic castration resistant prostate cancer
Radium-223 for bone predominant metastatic castration resistant prostate cancer
FALCON: Impact of 18F-fluciclovine PET/CT on management of biochemically recurrent prostate cancer
PROSPER RCC study of perioperative nivolumab for renal cell carcinoma - future trial
POUT: Phase III randomised trial of perioperative chemotherapy vs surveillance in upper tract urothelial cancer
Latest in adjuvant therapy for renal cell carcinoma
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer
Cancer control and care in the Middle East and North Africa
Guidelines and genomic factors for endometrial cancer
Options for breast reconstruction for younger breast cancer patients
Recommendation guidelines in breast cancer resolution for the Eastern Mediterranean
Cancer prevention in low and middle income countries
Breast cancer in young women from Asia